Paper Chase is a research database designed to offer abstracts of research articles published in journals that have a highly rated impact factor as determined by ISI Impact Factor and PageRank. Abstracts are organized by date, with the most recently published papers listed first. 

Paper Chase

241.

Cholera.

Lancet.
Harris JB, LaRocque RC, Qadri F, Ryan ET, Calderwood SB.
| Jun 30, 2012
242.

Co-formulated elvitegravir, cobicistat, emtricitabine, and tenofovir versus co-formulated efavirenz, emtricitabine, and tenofovir for initial treatment of HIV-1 infection: a randomised, double-blind, phase 3 trial, analysis of results after 48 weeks.

Lancet.
Sax PE, DeJesus E, Mills A, Zolopa A, Cohen C, Wohl D, Gallant JE, Liu HC, Zhong L, Yale K, White K, Kearney BP, Szwarcberg J, Quirk E, Cheng AK, Akil B.
| Jun 30, 2012
243.

Pulmonary embolism and deep vein thrombosis.

Lancet.
Goldhaber SZ, Bounameaux H.
| May 12, 2012
244.

Are we ready to recommend aspirin for cancer prevention?

Lancet.
Chan AT, Cook NR.
| Apr 28, 2012
245.

Towards regenerative therapy for cardiac disease.

Lancet.
Ptaszek LM, Mansour M, Ruskin JN, Chien KR.
| Mar 10, 2012
246.

Improving medication safety.

Lancet.
Schnipper JL, Rothschild JM.
| Apr 07, 2012
247.

Survival of children with burn injuries.

Lancet.
Tompkins RG.
| Mar 17, 2012
248.

Lapatinib with trastuzumab for HER2-positive early breast cancer (NeoALTTO): a randomised, open-label, multicentre, phase 3 trial.

Lancet.
Baselga J, Bradbury I, Eidtmann H, Di Cosimo S, de Azambuja E, Aura C, Gómez H, Dinh P, Fauria K, Van Dooren V, Aktan G, Goldhirsch A, Chang TW, Horváth Z, Coccia-Portugal M, Domont J, Tseng LM, Kunz G, Sohn JH, Semiglazov V, Lerzo G, Palacova M, Probachai V, Pusztai L, Untch M, Gelber RD, Piccart-Gebhart M, Lerzo G.
| Feb 18, 2012
249.

β-agonists for ARDS: the dark side of adrenergic stimulation?

Lancet.
Thompson BT.
| Jan 21, 2012
250.

Bioartificial tissues and organs: are we ready to translate?

Lancet.
Ott HC, Mathisen DJ.
| Dec 10, 2011
251.

Statins and safety: can we finally be reassured?

Lancet.
Kohli P, Cannon CP.
| Dec 10, 2011
252.

Denosumab and bone-metastasis-free survival in men with castration-resistant prostate cancer: results of a phase 3, randomised, placebo-controlled trial.

Lancet.
Smith MR, Saad F, Coleman R, Shore N, Fizazi K, Tombal B, Miller K, Sieber P, Karsh L, Damião R, Tammela TL, Egerdie B, Van Poppel H, Chin J, Morote J, Gómez-Veiga F, Borkowski T, Ye Z, Kupic A, Dansey R, Goessl C.
| Jan 07, 2012
253.

Medical complications associated with earthquakes.

Lancet.
Bartels SA, VanRooyen MJ.
| Feb 25, 2012
254.

Aspirin and colorectal cancer prevention in Lynch syndrome.

Lancet.
Chan AT, Lippman SM.
| Dec 17, 2011
255.

Time for zero deaths from tuberculosis.

Lancet.
Keshavjee S, Harrington M, Gonsalves G, Chesire L, Farmer PE.
| Oct 22, 2011
256.

A global scope for global health--including mental health.

Lancet.
Raviola G, Becker AE, Farmer P.
| Nov 05, 2011
257.

Accurate hypertension diagnosis is key in efficient control.

Lancet.
Gaziano TA.
| Oct 01, 2011
258.

Folate and cardiovascular disease: one size does not fit all.

Lancet.
Rimm EB, Stampfer MJ.
| Aug 13, 2011
260.

Co-stimulation modulation with abatacept in patients with recent-onset type 1 diabetes: a randomised, double-blind, placebo-controlled trial.

Lancet.
Orban T, Bundy B, Becker DJ, DiMeglio LA, Gitelman SE, Goland R, Gottlieb PA, Greenbaum CJ, Marks JB, Monzavi R, Moran A, Raskin P, Rodriguez H, Russell WE, Schatz D, Wherrett D, Wilson DM, Krischer JP, Skyler JS, Skyler JS.
| Jul 30, 2011